Emerging Therapies and Therapeutic Targets for Composite Liver Disease: NASH.
Sobhia ME, Kumari S, Kumar H, Gandhe A, Kaushik D, Kumar H, Jain J, Ankita, Mallick M, Pavani B, Moudgil M, Patel D.
Sobhia ME, et al. Among authors: pavani b.
Curr Top Med Chem. 2023;23(21):2027-2047. doi: 10.2174/1568026623666230714113808.
Curr Top Med Chem. 2023.
PMID: 37455455
Review.